Clinical Trial Update: Tirzepatide (Spartina) in Obese Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tirzepatide (Spartina) in obese kidney transplant recipients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Spartina (tirzepatide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Tirzepatide | Phase 4 | Status: RECRUITING